BDBM326318 3-{4-(3-chlorophenyl)-7- methyl-5-[(trans-4- methylcyclohexyl)methyl]- 5H-pyrrolo[3,2- d]pyrimidin-2-yl}-1,2,4- oxadiazol-5(4H)-one::US9637493, 5.2

SMILES C[C@H]1CC[C@H](Cn2cc(C)c3nc(nc(-c4cccc(Cl)c4)c23)-c2noc(=O)[nH]2)CC1

InChI Key InChIKey=YZZDUNHDLCSNJT-UHFFFAOYSA-N

Data  1 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 1 hit for monomerid = 326318   

TargetE3 ubiquitin-protein ligase Mdm2 [17-125](Human)
Merck Sharp & Dohme

US Patent
LigandPNGBDBM326318(3-{4-(3-chlorophenyl)-7- methyl-5-[(trans-4- methy...)
Affinity DataIC50: 107nMAssay Description:Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/29/2019
Entry Details
Go to US Patent